Ignite Creation Date:
2024-07-17 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06472388
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-05-03
Brief Title:
Everolimus 5 mg vs 10 mgDaily for Patients With Neuroendocrine Tumors
Sponsor:
AC Camargo Cancer Center
Organization:
AC Camargo Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-03
First Submit QC Date:
None
Study First Post Date:
2024-06-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-18
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL